2019 Biomedical HIV Prevention Summit Impact Report

2019 impact NOW! report

REGISTER

biomedical HIV prevention

summit December 3-4, 2019 | Houston, TX Marriott Marquis Houston www.biomedicalhivsummit.org #2019BHPS

ABOUT THE SUMMIT The fourth annual Biomedical HIV Prevention Summit was held in Houston, Texas,

Dec. 3-4 2019. The response to this year’s Summit showed the growing importance of biomedical prevention in the fight against HIV and also the new federal plan to End the Epidemic.

More than 1,400 people from around the nation came to Houston for the Summit, demonstrating the sustained need for this conference, particularly as plans to End the Epidemic are developed and implemented. The turnout also shows the ongoing importance of the Summit in the future.

Format The Summit centers on four plenaries for all conference attendees that explore major issues in greater detail. Unlike USCA, Summit plenaries are held in the round to create a greater sense of intimacy in the space.

This year, the Summit offered more than 40 workshops covering a variety of topics related to biomedical prevention and its use by communities at risk.

The 2019 Summit was the third year for the popular “Community Corner” sessions. These 15-minute presentations scheduled in-between workshops provided additional opportunities for education on a variety of biomedical prevention topics.

2

2019 BIOMEDICAL HIV PREVENTION SUMMIT

OPENING RECEPTION Welcome Reception The Summit Host Committee held a welcome reception at the pool deck of the Houston Marriott Marquis, the Summit host hotel. Featuring live performances to reflect the diversity of Houston, the reception was an opportunity to mingle in a casual setting.

2019 BIOMEDICAL HIV PREVENTION SUMMIT

3

PLENARIES There were four plenaries held during the Summit.

The Summit’s opening plenary, “Biomedical HIV Prevention Research and Women,” delved into the importance of biomedical HIV prevention for women and why there are gaps in research and use of such tools by women. It also featured a tribute for trans lives lost to violence in 2019.

Ken Williams, plenary host

Houston Mayor Sylvester Turner

Plenary panel (Leisha McKinleyBeach, Danielle M. Campbell, Dr. Charlene Flash, Dr. Tosha Rogers, and Brittany Williams)

Honoring transgender lives lost to violence

4

2019 BIOMEDICAL HIV PREVENTION SUMMIT

PLENARIES “The Federal Plan to End the HIV Epidemic and the Role of Implementation Research” looked at the fundamentals of implementation science as it relates to the execution of engagement and retention strategies for people living with HIV and those at risk of infection that can benefit from biomedical HIV prevention modalities.

Harold J. Phillips, Senior HIV Advisor and Chief Operating Officer of Ending the HIV Epidemic: A Plan for America

(Above) David Purcell, JD, PhD, Deputy Director for Behavioral and Social Science, DHAP, Centers for Disease Control and Prevention (Right) Jhetari Carney, MPH, Health Resources and Services Administration

Captain Timothy Holtz, MD, MPH, Deputy Director, NIH Office of AIDS Research

Neeraj Gandotra, MD, Chief Medical Officer, SAMHSA

2019 BIOMEDICAL HIV PREVENTION SUMMIT

5

PLENARIES “Long Acting Injectables and the MOSAICO Vaccine Study: The New Paradigm on Biomedical HIV Prevention,” Wednesday’s breakfast plenary, discussed new HIV prevention modalities under study, including long acting injectables.

Ken Williams asks attendees about their thoughts on injectables and implants to prevent HIV

(Above) Sheldon D. Fields, PhD, The SDF Group, LLC Innovation Consultants

(Right) Ken Williams and Stephaun E. Wallace, PhD, MS, MOL, HIV Vaccine Trials Network

The Summit’s Closing Plenary, “HIV Criminalization and Biomedical HIV Prevention,” focused on how currently available biomedical HIV prevention techniques are being used to support the modernization of HIV Criminalization statutes.

NMAC Executive Director Paul Kawata speaks

(L to R) Nikko Briteramos, Los Angeles, CA; Kamaria Laffrey, HIV Consultant, Winter Haven, FL; Scott A. Schoettes, Lambda Legal, Chicago, IL; and moderator Ace Robinson, Director of Strategic Partnerships at NMAC

The Houston Host Committee closes the 2019 Summit

6

2019 BIOMEDICAL HIV PREVENTION SUMMIT

EXHIBITORS

Table Company

Table Company

1:

Gilead

18:

Express Med

2:

AIDSVu

19:

Abbott

3:

CCN Pharmacy

20: Help Center for LGBT Health and Wellness

4:

Curant Health

21:

5:

CAPTC

22: Health HIV

6:

Until There’s A Cure Foundation

23: RDE Systems

7:

ViiV

24: Janssen

8:

Texas Action Health

25: Chembio Diagnostics Center

9:

Say it with a Condom

26: In the Meantime Men’s Group

San Francisco Department of Public Health

10: Avita

27: Texas State Department of Health

11:

Multicultural AIDS Coalition

28: Pharm Blue

12:

Capacity for Health

29: FC2 Internal Condom

13:

Walgreens

30: B Holding Group

14:

Please Prepare Me

31:

15:

Healthvana

32: Bowtie Movement

16:

Prevention Access Campaign

33: Biolytical Laboratories

17:

Nurx

34: Host Committee

R&S Northeast

2019 BIOMEDICAL HIV PREVENTION SUMMIT

7

ATTENDANCE 2019 BHPS Attendance by Age Range*

2019 BHPS Attendance by Ethnicity*

8 2019 BIOMEDICAL HIV PREVENTION SUMMIT

ATTENDANCE 2019 BHPS Attendance by Gender Identity

2019 BHPS Attendance by HIV Status

2019 BIOMEDICAL HIV PREVENTION SUMMIT

9

ATTENDANCE

2019 BHPS Attendance by Sexuality

Mobile App Performance

885 Users

Total number of unique users across devices

10

780 Total

Logged In Users

83.8K 8.41K 30.3K 22K All User Minutes Navigation Engagement

Total number of actions across all users taken with the app (i.e., sessions, speakers, exhibitors… etc.)

2019 BIOMEDICAL HIV PREVENTION SUMMIT

Contributors Total number of attendee messages and social shares

Open

Total time spent in minutes, users used the app

Icon Taps

Total number of taps for all navigation icons

QUANTITATIVE DATA

2019 BIOMEDICAL HIV PREVENTION SUMMIT 11

QUANTITATIVE DATA

12

2019 BIOMEDICAL HIV PREVENTION SUMMIT

QUANTITATIVE DATA

2019 BIOMEDICAL HIV PREVENTION SUMMIT

13

QUANTITATIVE DATA

14

2019 BIOMEDICAL HIV PREVENTION SUMMIT

QUANTITATIVE DATA

2019 BIOMEDICAL HIV PREVENTION SUMMIT

15

QUANTITATIVE DATA

16

2019 BIOMEDICAL HIV PREVENTION SUMMIT

QUANTITATIVE DATA Quotes & Affirmations

“The Biomedical HIV Prevention Summit was the best conference for me as a peer and executive officer in this HIV public health work. I enjoyed it from start to finish.”

- Jermaine Mondell, Greensboro, NC

Everything its the best conference ever i loved the conversations on sisters of color ive never walked away inspired before.

“One thing that this week’s Biomedical HIV Prevention Summit demonstrated was how critical it is that we fully integrate Community into all aspects of the work if we are ever to End the Epidemic! The science is amazing but even the research requires full participation of community to have results that are relevant.”

- Christopher Hucks-Ortiz

Extremely well organized and run conference.

Conference staff were super helpful and kind. The venue seemed perfect in regards to space, conference rooms, hotel rooms, and great food. The conference contained very relevant, educational information, and tools with knowledgeable speakers.

Overall summit theme, especially the opening plenary: my favorite as it validated my knowledge and WILL to do all I can to hear the voice, be the voice, and apply what I feel is my innate ability to encourage Black Women, and others to be their authentic selves and contribute in whatever manner they are gifted to help End HIV as an Epidemic in Texas, and beyond. As a Black woman w/ AIDS for 35yrs, I am determined to do even more via my vast networks-RWPC, DHTF Stigma Group, FastTrack,CABs etc

“Attending the Biomedical HIV Prevention Summit was simply life changing…I’m empowered, I’m inspired, and I’m looking forward to this path that God has created just for me.”

- Chase Edward Hale

The fact that cisgender black women were (finally) given a seat at the table surrounding the discussion on ending the HIV epidemic, instead of just MSM—it was important that the conference reinforced that PrEP is for everyone.

I really loved the plenaries.

Every plenary speaker was amazing! I loved the app use. Everything was ok n the app and made everything so easy to schedule, know where to go, and the interaction.

The phenomenal sessions that’s ranged pretty dramatically in terms of topics. I also liked the focus on Cis women of color in particular black cis women and increase the uptake of PrEP in this community given current uptake is so low

2019 BIOMEDICAL HIV PREVENTION SUMMIT

17

NMAC BOARD & STAFF STAFF Executive Office Paul Akio Kawata, Executive Director Kim Ferrell, Director of Operations

Development Robert York, Director of Development Diane Ferguson, Development Associate

Conferences Tara Barnes-Darby, Director of Conferences Alison J. McKeithen, Conferences Manager Shanta’ Gray, Conferences and Registration Coordinator Terrell Parker, Associate Program Manager Gabriella Spencer, Program Associate Communications Chip Lewis, Director of Communications

NMAC Training Center to End the Epidemic Ace Robinson, Director of Strategic Partnerships Charles Shazor Jr., Program Coordinator Treatment Moisés Agosto-Rosario, Director of Treatment Joanna Lopez, Associate Program Manager Government Relations Joe Huang-Racalto, Director of Government Relations & Public Policy

Finance and Administrative Division Bis Dhar, Director Ron Dorsey, Consultant

BOARD OF DIRECTORS Chair John W. Hill, Jr., Washington, DC Co-Chair Lance Toma, San Francisco Community Health Center, San Francisco, CA

Secretary Therese Rodriguez, Asian Pacific Islander Coalition on HIV/AIDS, New York, NY

Treasurer Valerie Rochester, AIDS United, Washington, DC

BOARD MEMBERS Oscar De La O Bienestar Human Services Los Angeles, CA Brenda Hunt Borderbelt AIDS Resource Team (BART) Lumberton, NC Monica Johnson HEROES - Helping Everyone Receive Ongoing Effective Support Columbia, LA Kelsey Louie, MSW, MBA Gay Men’s Health Crisis (GMHC) New York, NY Norm Nickens San Francisco Employees’ Retirement System San Francisco, CA Leonardo Ramon Ortega, MD, MPH Shalom Health Care Center, Inc. Indianapolis, IN

18

2019 BIOMEDICAL HIV PREVENTION SUMMIT

Mario Perez County of Los Angeles Department of Public Health Office of AIDS Programs & Policy Los Angeles, CA Rev. Ed Sanders Metropolitan Interdenominational Church Nashville, TN Evelyn Ullah Broward County, FL Rodolfo R. Vega JSI Research & Training Institute, Inc. Boston, MA Carlos E. Rodríguez-Díaz, PhD, MPHE, MCHES DC CFAR Milken Institute School of Public Health, George Washington University Washington, DC

THANK YOU TO OUR SPONSORS PRESENTING

BENEFACTOR

SUPPORTER

ALLY

2019 BIOMEDICAL HIV PREVENTION SUMMIT

19